Vesa Juvonen

Turku, Finland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

The KMT2A recombinome of acute leukemias in 2023.

The KMT2A recombinome of acute leukemias in 2023.

Journal: Leukemia

Published: February 08, 2023

Value of flow cytometry for MRD-based relapse prediction in B-cell precursor ALL in a multicenter setting.

Value of flow cytometry for MRD-based relapse prediction in B-cell precursor ALL in a multicenter setting.

Journal: Leukemia

Published: June 29, 2020

Correction: Minimal residual disease quantification by flow cytometry provides reliable risk stratification in T-cell acute lymphoblastic leukemia.

Correction: Minimal residual disease quantification by flow cytometry provides reliable risk stratification in T-cell acute lymphoblastic leukemia.

Journal: Leukemia

Published: December 12, 2019

Human MLL/KMT2A gene exhibits a second breakpoint cluster region for recurrent MLL-USP2 fusions.

Human MLL/KMT2A gene exhibits a second breakpoint cluster region for recurrent MLL-USP2 fusions.

Journal: Leukemia

Published: January 17, 2019

Minimal residual disease quantification by flow cytometry provides reliable risk stratification in T-cell acute lymphoblastic leukemia.

Minimal residual disease quantification by flow cytometry provides reliable risk stratification in T-cell acute lymphoblastic leukemia.

Journal: Leukemia

Published: September 04, 2018

The MLL recombinome of acute leukemias in 2017.

The MLL recombinome of acute leukemias in 2017.

Journal: Leukemia

Published: February 27, 2017

Minimal residual disease of leukemia and the quality of cryopreserved human ovarian tissue in vitro.

Minimal residual disease of leukemia and the quality of cryopreserved human ovarian tissue in vitro.

Journal: Leukemia & lymphoma

Published: July 01, 2015

Comparative analysis of minimal residual disease detection by multiparameter flow cytometry and enhanced ASO RQ-PCR in multiple myeloma.

Comparative analysis of minimal residual disease detection by multiparameter flow cytometry and enhanced ASO RQ-PCR in multiple myeloma.

Journal: Blood cancer journal

Published: August 24, 2014

The MLL recombinome of acute leukemias in 2013.

The MLL recombinome of acute leukemias in 2013.

Journal: Leukemia

Published: March 25, 2013

Assessment of molecular remission rate after bortezomib plus dexamethasone induction treatment and autologous stem cell transplantation in newly diagnosed multiple myeloma patients.

Assessment of molecular remission rate after bortezomib plus dexamethasone induction treatment and autologous stem cell transplantation in newly diagnosed multiple myeloma patients.

Journal: British journal of haematology

Published: December 05, 2012

Bone marrow remission status predicts leukemia contamination in ovarian biopsies collected for fertility preservation.

Bone marrow remission status predicts leukemia contamination in ovarian biopsies collected for fertility preservation.

Journal: Leukemia

Published: October 20, 2012

Showing 1-11 of 11

Last Updated: 09/26/2026